AMPL vs MRNA · rev $194.4M vs rev $145.0M
Amplitude Inc (AMPL) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Amplitude Inc (AMPL) is a software - application company listed on NASDAQ.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported AMPL revenue for 2026-06-30 was $194.4M. Net income was -$57.9M. AMPL currently screens at market cap $893.9M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
AMPL currently screens at market cap $893.9M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the AMPL and MRNA stock pages for the full models.
Not investment advice.